# Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

> **NCT00859703** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 20 (actual)

## Conditions studied

- Breast Cancer
- Menopause
- Osteopenia

## Interventions

- **DRUG:** Risedronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00859703
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859703, "Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00859703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*